C115H106Cl5N47O5 — CID 159926993
1-benzyl-3-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-(cyclohexylmethyl)urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-cyclopentylurea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-[(1-methylazetidin-3-yl)methyl]urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-(1-methylpiperidin-4-yl)urea (PubChem CID 159926993) has the molecular formula C115H106Cl5N47O5 and a molecular weight of 2403.70 g/mol. Its IUPAC name is 1-benzyl-3-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-(cyclohexylmethyl)urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-cyclopentylurea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-[(1-methylazetidin-3-yl)methyl]urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-(1-methylpiperidin-4-yl)urea.
| Compound Name | 1-benzyl-3-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-(cyclohexylmethyl)urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-cyclopentylurea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-[(1-methylazetidin-3-yl)methyl]urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-(1-methylpiperidin-4-yl)urea |
|---|---|
| PubChem CID | 159926993 |
| Molecular Formula | C115H106Cl5N47O5 |
| Molecular Weight | 2403.70 g/mol |
| Exact Mass | 2399.79 |
| IUPAC Name | 1-benzyl-3-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-(cyclohexylmethyl)urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-cyclopentylurea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-[(1-methylazetidin-3-yl)methyl]urea;1-[5-(7-chloro-1H-indazol-5-yl)-3-cyano-6-(1-methylpyrazol-3-yl)pyrazin-2-yl]-3-(1-methylpiperidin-4-yl)urea |
| SMILES | CN1CC(CNC(=O)Nc2nc(-c3ccn(C)n3)c(-c3cc(Cl)c4[nH]ncc4c3)nc2C#N)C1.CN1CCC(NC(=O)Nc2nc(-c3ccn(C)n3)c(-c3cc(Cl)c4[nH]ncc4c3)nc2C#N)CC1.Cn1ccc(-c2nc(NC(=O)NC3CCCC3)c(C#N)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cn1ccc(-c2nc(NC(=O)NCC3CCCCC3)c(C#N)nc2-c2cc(Cl)c3[nH]ncc3c2)n1.Cn1ccc(-c2nc(NC(=O)NCc3ccccc3)c(C#N)nc2-c2cc(Cl)c3[nH]ncc3c2)n1 |
| InChI | InChI=1S/C24H24ClN9O.C24H18ClN9O.C23H23ClN10O.C22H21ClN10O.C22H20ClN9O/c2*1-34-8-7-18(33-34)22-21(15-9-16-13-28-32-20(16)17(25)10-15)29-19(11-26)23(30-22)31-24(35)27-12-14-5-3-2-4-6-14;1-33-6-3-15(4-7-33)27-23(35)30-22-18(11-25)28-20(21(29-22)17-5-8-34(2)32-17)13-9-14-12-26-31-19(14)16(24)10-13;1-32-10-12(11-32)8-25-22(34)29-21-17(7-24)27-19(20(28-21)16-3-4-33(2)31-16)13-5-14-9-26-30-18(14)15(23)6-13;1-32-7-6-16(31-32)20-19(12-8-13-11-25-30-18(13)15(23)9-12)27-17(10-24)21(28-20)29-22(33)26-14-4-2-3-5-14/h7-10,13-14H,2-6,12H2,1H3,(H,28,32)(H2,27,30,31,35);2-10,13H,12H2,1H3,(H,28,32)(H2,27,30,31,35);5,8-10,12,15H,3-4,6-7H2,1-2H3,(H,26,31)(H2,27,29,30,35);3-6,9,12H,8,10-11H2,1-2H3,(H,26,30)(H2,25,28,29,34);6-9,11,14H,2-5H2,1H3,(H,25,30)(H2,26,28,29,33) |
| InChIKey | NZDKKEAZAOXRMK-UHFFFAOYSA-N |
| XLogP | 18.71 |
| TPSA | 692.48 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2403.70 |
| LogP ≤ 5 | 18.71 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 37 |